Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Neoadjuvant Letrozole for Postmenopausal ER/PR+ Breast Cancer
NCT00084396Phase 2Completed
- Sponsor
- Washington University School of Medicine
- Start
- Oct 2003
- Primary completion
- Mar 2007
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of letrozole in breast cancer, sponsored by Washington University School of Medicine. Started Oct 2003; status: completed.
02
Drugs
letrozole
03
Conditions
breast cancer
Beyond the preview
Go deeper on NCT00084396.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00084396.